hsa-mir-1301: Hsa-mir-1301 is a newly identified miRNA gene located at chromosome 2p23.3 that can produce two mature miRNAs, miR-1301-3p and miR-1301-5p [PMC8767067]. It has been reported that hsa-mir-1301, along with hsa-miR-1307 and hsa-miR-2110, is specific to Epstein-Barr virus-induced oropharyngeal cancer [PMC4449560]. The representative star sequence of hsa-mir-1301 has not been detected in low abundance known miRNAs [PMC2835764]. Hsa-mir-1301 has been found to be co-expressed with hsa-miR-320a [PMC7467934]. It is included in a risk assessment model along with other miRNAs for prostate cancer [PMC9911505]. Hsa-mir-1301, along with other miRNAs, has shown interactions with a specific number of genes [PMC2774487]. Overexpression of hsa-mir-1301 has been found to promote prostate cancer proliferation [PMC6049507]. In the context of gliomas, several low-expressed miRNAs have been studied in detail, but hsa-mir-1301 is not specifically mentioned [PMC6132976]. In chemoresistant cells compared to chemosensitive cells, hsa-mir-1301 is one of the upregulated DE-miRNAs identified [PMC6756437]. Hsa-mir-1301 is one of the m7G-related miRNAs associated with the survival of UCEC patients, and its high expression is associated with lower survival rates in UCEC patients [PMC9713471] [PMC8806668].
Sequence features are shown above as colored rectangles. Zoom in and click to view details, or Reset
View annotations in different species by clicking on species names.